Some clinicians use TA1 offlabel to support patients with autoimmune disease, citing its ability to modulate the immune system without broad suppression
Factors such as: Degree of insulin resistance Presence of other conditions (cardiovascular disease, fatty liver disease, sleep apnoea) Family history of diabetes or obesity Age and menopausal status Previous weight loss attempts and patterns of weight regain Safety considerations and tolerability play an important role
The potential cardiovascular benefits of GLP-1RA
They still do not protect against sunburn, so sunscreen remains necessary
Topical BPC-157 is the least studied of the three forms, but early data suggests potential benefits for surface-level wound healing, skin repair, and localized inflammation
Some suggest L-carnitine supplementation can lead to modest fat loss, particularly when combined with exercise